To investigate the pre-vaccination epidemiology of genital human papillomavirus (HPV) infections and genotypes in pregnant Japanese women, we performed Pap smear tests and HPV genotype testing in patients attending Nagasaki University Hospital and collaborating hospitals from August 2007 to July 2010. Serial uterine cervical specimens were obtained from 151 pregnant women. The HPV test was positive on the first visit in 54 women (35.8%; 54/151, average age 30). A total of 49 women (32.5%; 49/151) were infected by at least one high-risk HPV and 5 women were infected by only low-risk HPV. The three most prevalent high-risk HPV genotypes were HPV 52 (31.5%; 17/54), HPV 16 (29.6%; 16/51) and HPV 31 (13.0%; 7/51). The HPV infection pattern (negative, single infection and multiple infection) differed significantly according to the pregnancy trimester (v 2 -test; Po0.01(Pearson)). Among HPV-infected pregnant Japanese women, HPV52 was the most common genotype. The second most common genotype was HPV16, and these two genotypes accounted for B60% of HPV-positive pregnant women. Infection with multiple HPV genotypes was observed more frequently in the first trimester of pregnancy and the pattern of infection changed significantly depending on pregnancy stage. (2011) 56, 313-315; doi:10.1038/jhg.2011 published online 10 February 2011 Keywords: epidemiology; genotype; HPV; infection; pregnancy; uterine cervical neoplasia INTRODUCTION Persistent infections with human papillomavirus (HPV) are recognized as a major cause of cervical cancer. Genital infections with HPV are very common, and these infections are transmitted by sexual contact. 1 In most cases, HPV infections disappear naturally in a relatively short time period and carry only a small risk of disease development; 2-4 however, some investigators believe that pregnancy affects the host immune system; for example, pregnancy is believed to reduce seroreactivity against HPV infection. 5 Estrogen and progesterone have been shown to activate the upstream regulatory region of HPV18 (see ref. 6). Thereby altering HPV clearance rates compared with non-pregnant women. During persistent infection, important factors of disease susceptibility include HPV genotypes and viral characteristics, such as the distribution of each type in the population and the evasive ability against the host's immune system. It is not clear how persistent infection relates to the host, such as how the host immune system reacts against a specific HPV genotype and how sexual behavior in pregnant women affects infection rates. In particular, there are very few data detailing HPV genotype prevalence in pregnant Japanese women. To determine the distribution of HPV infections in pregnant Japanese women, we performed HPV genotype testing.
INTRODUCTION
Persistent infections with human papillomavirus (HPV) are recognized as a major cause of cervical cancer. Genital infections with HPV are very common, and these infections are transmitted by sexual contact. 1 In most cases, HPV infections disappear naturally in a relatively short time period and carry only a small risk of disease development; [2] [3] [4] however, some investigators believe that pregnancy affects the host immune system; for example, pregnancy is believed to reduce seroreactivity against HPV infection. 5 Estrogen and progesterone have been shown to activate the upstream regulatory region of HPV18 (see ref. 6 ). Thereby altering HPV clearance rates compared with non-pregnant women. During persistent infection, important factors of disease susceptibility include HPV genotypes and viral characteristics, such as the distribution of each type in the population and the evasive ability against the host's immune system. It is not clear how persistent infection relates to the host, such as how the host immune system reacts against a specific HPV genotype and how sexual behavior in pregnant women affects infection rates. In particular, there are very few data detailing HPV genotype prevalence in pregnant Japanese women. To determine the distribution of HPV infections in pregnant Japanese women, we performed HPV genotype testing.
MATERIALS AND METHODS

Study population and sample collection
Cytology and HPV DNA test samples were collected by six hospitals that collaborated with Nagasaki University Hospital from August 2007 to July 2010. All pregnant women whose first visit during pregnancy was to one of our collaborating hospitals were invited to join the study. An obstetrics doctor explained the study aim, procedures and complications. We did not inform participants of the HPV genotyping results. Exclusion criteria were patients who had previously received therapeutic surgery or who had histologically confirmed non-squamous neoplasms. We registered 151 pregnant women having a routine Pap test screen for the study. Specimens were taken with a Cervex brush (Rovers Medical Devices, Oss, Netherlands) and suspended in 10 ml of SurePath preservative fluid (Becton Dickinson, Franklin Lakes, NJ, USA). We used sample from the same vial for cytology and for HPV genotype testing. Cervical specimens for HPV genotyping were taken at each visit from participants who received regular follow-up examinations.
The study protocol was approved by the ethical review board of Nagasaki University and of the other hospitals involved. All women were informed of the purpose of the study and gave their consent.
HPV genotyping test
Genotyping of HPV DNA in the SurePath preservative fluid was performed using the Linear Array HPV Genotyping Test kit (Roche Diagnostics, Indianapolis, IN, USA). The kit uses PGMY09/PGMY11 primers 7 to amplify the L1 conserved region. Following PCR amplification, hybridization of the HPV amplicon was performed using an array of oligonucleotide probes that allowed independent identification of individual HPV genotypes. This kit can detect 37 HPV genotypes (6, 11, 16, 18, 
RESULTS
A total of 151 women were enrolled in the study. In all, 79 women were in the first trimester of their pregnancy, 18 were in the second trimester, 51 were in the third trimester and 3 were postpartum. Fiftyfour women (35.8%; 54/151), with an average age of 30, were positive for HPV on their first hospital visit. Forty-nine women (32.5%; 49/ 151) were infected by at least one high-risk HPV and five women were infected by only low-risk HPV. The three most prevalent high-risk HPV genotypes were HPV 52 (31.5%; 17/54), HPV 16 (29.6%; 16/51) and HPV 31 (13.0%; 7/51) ( Table 1 ). The HPV infection pattern (negative, single infection and multiple infection) was significantly different depending on the trimester of the pregnancy (w 2 -test; Po0.01 (Pearson)).
DISCUSSION
The influence of pregnancy on the natural course of HPV infection is not understood. Several reports show that the prevalence of HPV infection in pregnant women is variable at 10-60%, depending on age, region and HPV detection methods. [11] [12] [13] [14] The HPV infection rate in pregnant women in this report was 35%. There are few reports of HPV infection rates in pregnant Japanese women. One report by Takakuwa et al. 15 showed the prevalence of HPV in pregnant Japanese women to be 12.5%. The difference between this report and our results may be because of the detection method used, PCR-reverse hybridization (our study) and PCR-restriction fragment length polymorphism (Takakuwa et al.) , and the number of detectable HPV genotypes.
Several other studies 16, 17 show the clearance of HPV infection may accelerate in the third trimester and postpartum. In our study, the HPV infection pattern differed significantly according to the pregnancy trimester. In particular, in the first trimester, multiple HPV infection was observed more often than in the later periods. This observation may be explained by changes in sexual behavior and/or by immunological factors. Pregnant women tend to be less sexually active and their immune response against HPV is reduced. The accelerated clearance of HPV may be due to the host immune system normalizing during the third trimester. 18 Our results showed that HPV 16 and HPV 52 were the two most common genotypes among pregnant Japanese women. Our data among 154 non-pregnant Japanese women also showed that HPV 16 and HPV 52 were the two most common genotype. The prevalence of HPV genotype in Japanese pregnant women may not show pregnant-specific features. Other reports using HPV genotyping tests also showed that HPV 52 was a more common genotype among Japanese individuals who had either normal cytology or cervical neoplastic lesions compared with individuals in other countries. 10, 19, 20 In Japan, a commercial cervical cancer vaccine finally became available after December 2009. This study has some limitations because we obtained data from pregnant women; however, our data from pre-vaccination women on the distribution of genital HPV infections in the region where HPV 52 is more prevalent are important for the understanding of the cross-reactivity of a bivalent HPV vaccine. 17, 21 Epidemiology of HPV in pregnant Japanese women K Yamasaki et al
